ArticleFrontiers in medicine2025

Assessment of the risk of discontinuation of tenofovir disoproxil fumarate after delivery and the benefit of continued treatment in patients with immune tolerance.

Huan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.